Anti-oxidant and anti-hyperglycemic activities of musa sapientum root extracts in alloxan-induced diabetic rats

摘要

Anti-hyperglycemic and anti-oxidant properties of methanolic (MEMS) and aqueous (AEMS) extracts of Musa sapientum roots were investigated in alloxan-induced diabetic rats. Thirty adult male Wistar albino rats divided into five groups of 6 rats each were used:- group 1 – non-diabetic untreated (controls), group 2 - diabetic untreated, and groups 3, 4 and 5 - diabetic rats treated with 250mg/kg bodyweight MEMS and AEMS, and 500mg/kg bodyweight glibenclamide (a standard anti-diabetic drug), respectively. There was severe progressive weight loss in the untreated diabetic rats, while the rats in all the treated diabetic groups gained weight. While there was progressive hyperglycaemia in untreated diabetic rats, with blood glucose levels reaching a peak of 335.5±1.1mg/dl on day 7 post-induction, compared to 76.8±0.8mg/dl on day 0, these values were reduced to 80.7±0.5, 86.6±0.6 and 86.8±0.5 in MEMS, AEMS and glibenclamide-treated diabetic rats 15 days post-treatment. Also there were decreases in serum lipid peroxidation and increases in serum superoxide dismutase activities in MEMS, AEMS and glibenclamide-treated diabetic rats 15 days post-treatment. Lesions observed in the organs of untreated diabetic rats include selective necrosis of pancreatic beta islet cells, hepatocellular degeneration and necrosis, glomerulonephrosis and cardiovascular degeneration. Treatment of diabetic rats with AEMS and glibenclamide caused a total mitigation, while treatment with the MEMS achieved partial but considerable reduction in the severity of the lesions. It is concluded that aqueous and methanolic extracts of Musa sapientum roots possess anti-diabetic activities comparable to glibenclamide.

Keywords: Diabetes mellitus, oxidative stress, Musa sapientum root extracts, anti-oxidant, antihyperglycaemic, Albino rats.

Résumé
Les propriétés antiglycémiantes et antioxydants du méthanol (MSME) et les extraits aqueux des racines de Musa Sapientum étaient investiguées en alloxane-induit chez les rats diabétiques. Trente rats adultes males wistar albinos divisés en cinq groupes de 6 rats chacun étaient utilisés : groupe :1- groupe Non diabétiques non traités( contrôle), Diabétiques non traités et groupe 3,4 et 5-rats diabétiques traités avec 250mg/kg de poids corporel MEMS et AEMS, et 500mg/kg de poids corporel, glibenclamide (un médicament antidiabétique standard) respectivement. Il y’avait une sévère perte progressive de poids chez les rats diabétiques non traités, alors que les rats de tous les groupes diabétiques traités prenaient du poids. Pendant qu’il y’avait une hyperglycémie progressive chez les rats diabétiques non traités, avec un taux de glucose dans le sang attenant un maximum de 335.5 ± 1.1mg/dl au jour 7 après l’induction, comparé a76.8 ± 0.8mg/dl au jour 0. Ces valeurs étaient réduite à 80.7 ± 0.5, 86.6 ± 0.6 et 86.8 ± 0.5 chez les rats diabétiques traités de MEMS, AEMS et glibenclamide, 15 jours après le traitement. Il y’avait aussi une baisse en peroxydation de sérum lipide et augmentation en activité de sérum superoxide dismutase chez les rats diabétiques traités en MEMS, AEMS et glibenclamide, 15 jours après le traitement. Les lésions observées sur les organes des rats diabétiques non traites inclus une nécrose sélective des cellules Beta du pancréas, la dégénération hépatocellulaire et la nécrose, glomérulonéphrite et la dégénération cardiovasculaire. Le traitement des rats diabétiques avec AEMS et glibenclamide a cause une mitigation totale, alors que le traitement avec le MEMS a atteint partiellement le but avec une réduction considérable de la sévérité de la lésion. Il est conclu que les extraits méthanoïques et aqueuse des racines de Musa sapientum ont des activités antidiabétiques comparable à la glibenclamide

Correspondence : Dr. Elsie O. Adewoye, Department of Physiology, College of Medicine, University of Ibadan, Ibadan, Nigeria. E-mail: elolade@yahoo.com

pdf (英语)

参考

Rosen P, Nawroth PP, King G, Moller W, Tritcher HJ and Packer I. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of the congress series sponsored by UNESCO – MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001; 17: 189 – 212.

Maritim AC. Diabetes, oxidative stress and anti oxidants: a review. J. Biochem. Mol. Toxicol. 2003; 19(1): 24 – 28.

Friedovich I. Superoxide dismutase. Ann. Rev. Biochem 1975; 44: 147.

Gurr AI and James AT. Lipid biochemistry: An introduction, 3rd ed. Wiley, 1980.

WHO Technical Report Series 727. Geneva 1985.

King H, Aubert RE and Herman WH. Global burden of diabetes 1995 – 2025. Prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414 – 1431.

Moram GS. Effect of aqueous extracts from some plants on alloxan diabetic rats. The Egypt J Hosp Med 2001; 2: 57 – 69.

Morton J.Banana. In: Fruits of Warm Climates. J.F. Morton, Miami Fl., 1987; 29 -46.

Iwu MM. Handbook of African Medicinal Plants. Boca Raton: CRC Press Inc., 1993.

Brinker, F. Botanical Medical Research Summaries. In: Eclectic Dispensary of Botanical Therapeutics, Vol. II. Eclectic Medical Publications: Sandy, OR, 1995.

Owoyele VB, Wuraola CO, Soladoye AO and Olaleye SB. Studies on the anti-inflammatory and analgesic properties of Tithonia diversifolia leaf extract. J Ethnopharmacol 2004; 90: 317–321.

Locke D. A new approach to acute toxicity testing. Arch Toxicol 192; 54: 275 – 287.

Mustafa SA. Toxic effects of alloxan in the rat. Mechanism and protection with Zinc. The Egypt J Hosp Med 2003; 10: 1-13.

Trinder P. Determination of blood glucose using an oxidase peroxidase system with a non–carcinogenic chromogen. J Clin Path 1969; 22: 158 – 161.

Varshney R and Kale RK. Effect of calmodulin antagonists on radiation induced lipid peroxidation in microsomes. Int J Biol 1990; 58: 733 – 743.

McCord JM, Keele BM and Fridovich I. An enzyme based theory of obligate anaerobics. The physiolo gical functions of superoxide dismutase. Proc Natl Acad Sci USA 1976; 68: 1024.

Koracevic D, Djordjevic V, Andrejevic S and Cosic V. Methods for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001; 54: 356 – 361.

SAS. Statistical Analysis Systems Users Guide, Version 6.03, SAS Institute Inc., Cary NC. 1987; p. 58.

Duncan RD. Multiple tests and multiple F tests. Biometrics 1959; 9: 1-59.

Atkinson M and Eisenbarth G. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001; 358 (9277): 221-229.

Aderibigbe AO, Emudianugbe TS and Lawal BAS. Antihyperglycemic effect of Mangifera indica in rats. Phytotherapy Res 1999; 13: 504 – 507.

Nammi S, Boini MK, Lodagala SD and Behara RB. The juice of fresh leaves of Catharanthus roseus Linn reduces blood glucose in normal and alloxan diabetic rats. BMC Compl Alt Med 2003; 5: 1 – 4.

Stefek M and Tmkova Z. The pyridoindole antioxidant stobadine prevents alloxan–induced lipid peroxidation by inhibiting its propagation. Pharmacol Toxicol 1996; 78 (2): 77 – 81.

Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813 – 820.

Tanaka Y, Tran PO, Harmon J and Robertson RP. A role for glutathione peroxidase in protecting pancreatic β– cells against oxidative stress in a model of glucose toxicity. Proc Natl Acad Sci USA 2002; 99(19): 12363 – 12368.

Sozmen EY, Sozmen B, Delen Y and Onat T. Catalase / Superoxide dismutase (SOD) and Catalase/ paraoxonase (PON) ratios may implicate poor glycemic control. Arch Med Res 2001; 32: 283 – 287.

Frier BM. Diabetes and myocardial infarction. Diabetes Rev Int 1998; 7: 1–2.

NIH/NIDDK. Department of Health and Human Services, National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892, 2000. http://www.niddk.nih.gov

Shishehbor MH, Aviles, RJ, Brennan ML, Fu X, Goormastic M, Pearce GL, Gokce N, Keaney JF, Jr, Penn MS, Sprecher DL, Vita JL and Hazen SL. J. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. J Am Med Assoc 2003; 289: 1675– 1680.

Ceriello A and Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 2004; 24: 816–823.